Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of Immunotherapy

Immunotherapy, including immune checkpoint inhibitors, tumor vaccine therapy, oncolytic virotherapy, and adoptive cell therapy, has made remarkably breakthroughs in the field of oncology. Immune checkpoint inhibitors, which block programmed death receptor 1 or programmed death ligand 1, have been in...

Full description

Saved in:
Bibliographic Details
Main Authors: Yufan CHEN, Sicong LI, Yiyuan CUI, Li FENG
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2025-01-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
Online Access:http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.0839
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590793541419008
author Yufan CHEN
Sicong LI
Yiyuan CUI
Li FENG
author_facet Yufan CHEN
Sicong LI
Yiyuan CUI
Li FENG
author_sort Yufan CHEN
collection DOAJ
description Immunotherapy, including immune checkpoint inhibitors, tumor vaccine therapy, oncolytic virotherapy, and adoptive cell therapy, has made remarkably breakthroughs in the field of oncology. Immune checkpoint inhibitors, which block programmed death receptor 1 or programmed death ligand 1, have been included in the first-line clinical treatment for advanced solid tumors, such as non-small cell lung cancer and malignant melanoma. However, primary or secondary drug resistance in tumors severely limits the survival benefits for patients. Immune-related adverse reactions, such as pneumonia, hypothyroidism, hypophysitis, and myocarditis, also greatly affect the quality of life of patients. Fuzheng Jiedu Huayu is an important concept guiding the prevention and treatment of tumors with traditional Chinese medicine (TCM). It is also a curative principle and therapeutic TCM method to reduce the toxicity and enhance the efficacy of immunotherapy. This article summarizes the research progress of immunotherapy and discusses how TCM reduces the toxicity and enhances the efficacy of immunotherapy, hoping to provide a reference for the integrated treatment of tumors with TCM and immunotherapy.
format Article
id doaj-art-12f97a5d8054487a8213b35f908ea6a7
institution Kabale University
issn 1000-8578
language zho
publishDate 2025-01-01
publisher Magazine House of Cancer Research on Prevention and Treatment
record_format Article
series Zhongliu Fangzhi Yanjiu
spelling doaj-art-12f97a5d8054487a8213b35f908ea6a72025-01-23T07:44:48ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85782025-01-01521111810.3971/j.issn.1000-8578.2025.24.083920240839Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of ImmunotherapyYufan CHEN0Sicong LI1Yiyuan CUI2Li FENG3Department of Traditional Chinese Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy for Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaDepartment of Traditional Chinese Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy for Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaDepartment of Traditional Chinese Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy for Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaDepartment of Traditional Chinese Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy for Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaImmunotherapy, including immune checkpoint inhibitors, tumor vaccine therapy, oncolytic virotherapy, and adoptive cell therapy, has made remarkably breakthroughs in the field of oncology. Immune checkpoint inhibitors, which block programmed death receptor 1 or programmed death ligand 1, have been included in the first-line clinical treatment for advanced solid tumors, such as non-small cell lung cancer and malignant melanoma. However, primary or secondary drug resistance in tumors severely limits the survival benefits for patients. Immune-related adverse reactions, such as pneumonia, hypothyroidism, hypophysitis, and myocarditis, also greatly affect the quality of life of patients. Fuzheng Jiedu Huayu is an important concept guiding the prevention and treatment of tumors with traditional Chinese medicine (TCM). It is also a curative principle and therapeutic TCM method to reduce the toxicity and enhance the efficacy of immunotherapy. This article summarizes the research progress of immunotherapy and discusses how TCM reduces the toxicity and enhances the efficacy of immunotherapy, hoping to provide a reference for the integrated treatment of tumors with TCM and immunotherapy.http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.0839malignant tumortraditional chinese medicinereduce toxicity and enhance efficiencyimmunotherapy
spellingShingle Yufan CHEN
Sicong LI
Yiyuan CUI
Li FENG
Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of Immunotherapy
Zhongliu Fangzhi Yanjiu
malignant tumor
traditional chinese medicine
reduce toxicity and enhance efficiency
immunotherapy
title Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of Immunotherapy
title_full Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of Immunotherapy
title_fullStr Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of Immunotherapy
title_full_unstemmed Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of Immunotherapy
title_short Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of Immunotherapy
title_sort research progress of fuzheng jiedu huayu method in reducing toxicity and enhancing efficacy of immunotherapy
topic malignant tumor
traditional chinese medicine
reduce toxicity and enhance efficiency
immunotherapy
url http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.0839
work_keys_str_mv AT yufanchen researchprogressoffuzhengjieduhuayumethodinreducingtoxicityandenhancingefficacyofimmunotherapy
AT sicongli researchprogressoffuzhengjieduhuayumethodinreducingtoxicityandenhancingefficacyofimmunotherapy
AT yiyuancui researchprogressoffuzhengjieduhuayumethodinreducingtoxicityandenhancingefficacyofimmunotherapy
AT lifeng researchprogressoffuzhengjieduhuayumethodinreducingtoxicityandenhancingefficacyofimmunotherapy